Aker Biomarine AS
Research Aker Biomarine AS (AKBM) on Bullrun: market cap NOK 8.38B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAKBM
- ExchangeOL
- CountryNorway
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyNOK
- Market capNOK 8.38B
- Financial periodFY2024
- RevenueUSD 199.00M
- Revenue growth1.4%
- Net incomeUSD 180.30M
- Free cash flow-USD 5.20M
- Gross margin34.7%
Valuation Snapshot
latest market cap is NOK 8.38B.
About Aker Biomarine AS
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. The company operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand;
Frequently asked questions
What is Aker Biomarine AS's market cap?
Aker Biomarine AS's market capitalization is NOK 8.38B.
What does Aker Biomarine AS do?
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. The company operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business.